MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA

MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA

FIELD: biotechnology, medicine, vaccines. ^ SUBSTANCE: invention relates to a mixed vaccine comprising some antigens in a single preparation. New mixed vaccine comprises the following components: hepatitis B virus surface antigen (HBsAg/ayw) prepared by culturing the yeast strain Pichia angusta VKM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MEL'NIKOV V.A, JAKOVLEVA I.M, BORISOVA V.N, BUDANOV M.V
Format: Patent
Sprache:eng ; rus
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MEL'NIKOV V.A
JAKOVLEVA I.M
BORISOVA V.N
BUDANOV M.V
description FIELD: biotechnology, medicine, vaccines. ^ SUBSTANCE: invention relates to a mixed vaccine comprising some antigens in a single preparation. New mixed vaccine comprises the following components: hepatitis B virus surface antigen (HBsAg/ayw) prepared by culturing the yeast strain Pichia angusta VKM Y-2924 D and/or hepatitis B virus surface antigen (HBsAg/adw) prepared by culturing the yeast strain H. polymorpha VKPM Y-2412 in the amount 5-10 mcg; diphtheria anatoxin, 5-10 Lf; tetanus anatoxin, 5-7.5 EC; aluminum hydroxide (Al3+) gel, 0.35-0.55 mg; merthiolate, 15-35 mcg, and 0.9% NaCl, up to 0.5 ml. Hepatitis B virus antigens (HBsAg/ayw) and (HBsAg/adw) are taken in vaccine in the ratio = 1:1. The novel mixed vaccine is high-immune, nontoxic preparation providing carry out immunization against pathogens of some diseases of viral and bacterial etiology. The application of invention provides expanding assortment of agents designated for simultaneous prophylaxis of viral hepatitis B and D, tetanus and diphtheria. ^ EFFECT: valuable medicinal properties of mixed vaccine. ^ 2 cl, 10 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2233672C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2233672C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2233672C13</originalsourceid><addsrcrecordid>eNqNiksKwjAUALNxIeod3gF0YQK6fs2HPGg-pGmoq1IkrkQL9f4o6AFcDTPMmhVHg1ZQUEryGkxIQM71PsQUor20OFAHwUChhC1YHTFT_qQG0CtQe8g6o--7r1K02epEuGWr23Rf6u7HDQOjs7SHOj_HuszTtT7qa0w950KczlwexR_LGx3dMCo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA</title><source>esp@cenet</source><creator>MEL'NIKOV V.A ; JAKOVLEVA I.M ; BORISOVA V.N ; BUDANOV M.V</creator><creatorcontrib>MEL'NIKOV V.A ; JAKOVLEVA I.M ; BORISOVA V.N ; BUDANOV M.V</creatorcontrib><description>FIELD: biotechnology, medicine, vaccines. ^ SUBSTANCE: invention relates to a mixed vaccine comprising some antigens in a single preparation. New mixed vaccine comprises the following components: hepatitis B virus surface antigen (HBsAg/ayw) prepared by culturing the yeast strain Pichia angusta VKM Y-2924 D and/or hepatitis B virus surface antigen (HBsAg/adw) prepared by culturing the yeast strain H. polymorpha VKPM Y-2412 in the amount 5-10 mcg; diphtheria anatoxin, 5-10 Lf; tetanus anatoxin, 5-7.5 EC; aluminum hydroxide (Al3+) gel, 0.35-0.55 mg; merthiolate, 15-35 mcg, and 0.9% NaCl, up to 0.5 ml. Hepatitis B virus antigens (HBsAg/ayw) and (HBsAg/adw) are taken in vaccine in the ratio = 1:1. The novel mixed vaccine is high-immune, nontoxic preparation providing carry out immunization against pathogens of some diseases of viral and bacterial etiology. The application of invention provides expanding assortment of agents designated for simultaneous prophylaxis of viral hepatitis B and D, tetanus and diphtheria. ^ EFFECT: valuable medicinal properties of mixed vaccine. ^ 2 cl, 10 ex</description><edition>7</edition><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040810&amp;DB=EPODOC&amp;CC=RU&amp;NR=2233672C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040810&amp;DB=EPODOC&amp;CC=RU&amp;NR=2233672C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEL'NIKOV V.A</creatorcontrib><creatorcontrib>JAKOVLEVA I.M</creatorcontrib><creatorcontrib>BORISOVA V.N</creatorcontrib><creatorcontrib>BUDANOV M.V</creatorcontrib><title>MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA</title><description>FIELD: biotechnology, medicine, vaccines. ^ SUBSTANCE: invention relates to a mixed vaccine comprising some antigens in a single preparation. New mixed vaccine comprises the following components: hepatitis B virus surface antigen (HBsAg/ayw) prepared by culturing the yeast strain Pichia angusta VKM Y-2924 D and/or hepatitis B virus surface antigen (HBsAg/adw) prepared by culturing the yeast strain H. polymorpha VKPM Y-2412 in the amount 5-10 mcg; diphtheria anatoxin, 5-10 Lf; tetanus anatoxin, 5-7.5 EC; aluminum hydroxide (Al3+) gel, 0.35-0.55 mg; merthiolate, 15-35 mcg, and 0.9% NaCl, up to 0.5 ml. Hepatitis B virus antigens (HBsAg/ayw) and (HBsAg/adw) are taken in vaccine in the ratio = 1:1. The novel mixed vaccine is high-immune, nontoxic preparation providing carry out immunization against pathogens of some diseases of viral and bacterial etiology. The application of invention provides expanding assortment of agents designated for simultaneous prophylaxis of viral hepatitis B and D, tetanus and diphtheria. ^ EFFECT: valuable medicinal properties of mixed vaccine. ^ 2 cl, 10 ex</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNiksKwjAUALNxIeod3gF0YQK6fs2HPGg-pGmoq1IkrkQL9f4o6AFcDTPMmhVHg1ZQUEryGkxIQM71PsQUor20OFAHwUChhC1YHTFT_qQG0CtQe8g6o--7r1K02epEuGWr23Rf6u7HDQOjs7SHOj_HuszTtT7qa0w950KczlwexR_LGx3dMCo</recordid><startdate>20040810</startdate><enddate>20040810</enddate><creator>MEL'NIKOV V.A</creator><creator>JAKOVLEVA I.M</creator><creator>BORISOVA V.N</creator><creator>BUDANOV M.V</creator><scope>EVB</scope></search><sort><creationdate>20040810</creationdate><title>MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA</title><author>MEL'NIKOV V.A ; JAKOVLEVA I.M ; BORISOVA V.N ; BUDANOV M.V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2233672C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MEL'NIKOV V.A</creatorcontrib><creatorcontrib>JAKOVLEVA I.M</creatorcontrib><creatorcontrib>BORISOVA V.N</creatorcontrib><creatorcontrib>BUDANOV M.V</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEL'NIKOV V.A</au><au>JAKOVLEVA I.M</au><au>BORISOVA V.N</au><au>BUDANOV M.V</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA</title><date>2004-08-10</date><risdate>2004</risdate><abstract>FIELD: biotechnology, medicine, vaccines. ^ SUBSTANCE: invention relates to a mixed vaccine comprising some antigens in a single preparation. New mixed vaccine comprises the following components: hepatitis B virus surface antigen (HBsAg/ayw) prepared by culturing the yeast strain Pichia angusta VKM Y-2924 D and/or hepatitis B virus surface antigen (HBsAg/adw) prepared by culturing the yeast strain H. polymorpha VKPM Y-2412 in the amount 5-10 mcg; diphtheria anatoxin, 5-10 Lf; tetanus anatoxin, 5-7.5 EC; aluminum hydroxide (Al3+) gel, 0.35-0.55 mg; merthiolate, 15-35 mcg, and 0.9% NaCl, up to 0.5 ml. Hepatitis B virus antigens (HBsAg/ayw) and (HBsAg/adw) are taken in vaccine in the ratio = 1:1. The novel mixed vaccine is high-immune, nontoxic preparation providing carry out immunization against pathogens of some diseases of viral and bacterial etiology. The application of invention provides expanding assortment of agents designated for simultaneous prophylaxis of viral hepatitis B and D, tetanus and diphtheria. ^ EFFECT: valuable medicinal properties of mixed vaccine. ^ 2 cl, 10 ex</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2233672C1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title MIXED VACCINE FOR IMMUNOPROPHYLAXIS OF VIRAL HEPATITIS B AND D, TETANUS AND DIPHTHERIA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEL'NIKOV%20V.A&rft.date=2004-08-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2233672C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true